Compare ROK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROK | BDX |
|---|---|---|
| Founded | 1903 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3B | 43.0B |
| IPO Year | 2004 | 1997 |
| Metric | ROK | BDX |
|---|---|---|
| Price | $464.63 | $153.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $406.20 | $186.00 |
| AVG Volume (30 Days) | 727.8K | ★ 2.3M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | 1.38% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.79 | 0.25 |
| Revenue | $6,666,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $7.46 | N/A |
| Revenue Next Year | $6.06 | $3.02 |
| P/E Ratio | ★ $79.05 | $621.72 |
| Revenue Growth | 5.62 | ★ 8.24 |
| 52 Week Low | $305.44 | $140.11 |
| 52 Week High | $497.36 | $213.08 |
| Indicator | ROK | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 51.82 |
| Support Level | $455.70 | $153.27 |
| Resistance Level | $465.80 | $159.72 |
| Average True Range (ATR) | 13.33 | 3.98 |
| MACD | -2.29 | 0.08 |
| Stochastic Oscillator | 35.01 | 36.15 |
With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software and control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.